These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7817275)

  • 1. [The lymphogenic metastatic pathways of thoracic esophageal carcinoma--their clinical and prognostic significance].
    Fietkau R
    Strahlenther Onkol; 1994 Dec; 170(12):719-20. PubMed ID: 7817275
    [No Abstract]   [Full Text] [Related]  

  • 2. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-pathological classification of carcinoma of the esophagus].
    Curto Cardús J; Alcobendas F; Benasco C
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):337-40. PubMed ID: 4001530
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
    Incarbone R; Bonavina L
    Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an appropriate staging system for esophageal carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A retrospective German-Austrian-Swiss Work Group study on carcinoma of the mouth: the prognostic relevance of various factors with reference to therapy].
    Platz H; Fries R; Hudec M
    Osterr Z Stomatol; 1983 Jun; 80(6):216-27. PubMed ID: 6583641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carcinoma of the endometrium: a neoplasm on the increase. Its staging and treatment: a proposed protocol].
    Baiocchi G; Gilardi G
    Minerva Ginecol; 1997; 49(1-2):1-5. PubMed ID: 9162878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discussion of the treatment of esophageal carcinoma,especially in the point of non-surgical treatments, from the viewpoint of medical oncology].
    Maeda Y; Sasaki E; Sasaki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):831-5. PubMed ID: 17565242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma].
    Xiao ZF; Yang ZY; Wang LH; Zhang HX; Feng QF; Chen DF; Zhou ZM; Zhang DC; Sun KL; Cheng GY; He J
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):112-5. PubMed ID: 15059333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
    Theisen J; Siewert JR
    MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative genomic hybridization analysis for esophageal squamous cell carcinoma.
    Oka M
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):275-6. PubMed ID: 15563260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of esophageal carcinoma.
    Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2003 May; 125(5):988-91. PubMed ID: 12771869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Statistical review of esophageal cancer in Japan].
    Kato H
    Nihon Rinsho; 1993 Jan; 51 Suppl():670-8. PubMed ID: 8459601
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
    Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
    Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cancer of the esophagus. New strategy with the multidisciplinary treatment].
    Hernández Lizoáin JL; Zornoza G; Calvo FA; Fernández-Hidalgo O; Santos M; Voltas J
    Rev Med Univ Navarra; 1989; 33(4):223-32. PubMed ID: 2490187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
    Chirieac LR; Swisher SG; Ajani JA; Komaki RR; Correa AM; Morris JS; Roth JA; Rashid A; Hamilton SR; Wu TT
    Cancer; 2005 Apr; 103(7):1347-55. PubMed ID: 15719440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.